Compare AXSM & SITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXSM | SITM |
|---|---|---|
| Founded | 2012 | 2003 |
| Country | United States | United States |
| Employees | 925 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 10.4B |
| IPO Year | 2015 | 2019 |
| Metric | AXSM | SITM |
|---|---|---|
| Price | $227.85 | $777.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 7 |
| Target Price | $211.12 | ★ $405.00 |
| AVG Volume (30 Days) | ★ 821.3K | 430.2K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.56 | ★ 57.53 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $326,660,000.00 |
| Revenue This Year | $57.24 | $49.65 |
| Revenue Next Year | $55.88 | $27.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 61.16 |
| 52 Week Low | $96.09 | $186.49 |
| 52 Week High | $235.92 | $901.81 |
| Indicator | AXSM | SITM |
|---|---|---|
| Relative Strength Index (RSI) | 69.80 | 67.61 |
| Support Level | $148.87 | $327.71 |
| Resistance Level | $234.29 | N/A |
| Average True Range (ATR) | 10.83 | 46.71 |
| MACD | 1.47 | 14.50 |
| Stochastic Oscillator | 85.57 | 68.92 |
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
SiTime Corp is a provider of Precision Timing solutions to the international electronics industry, providing the timing functionality needed for electronics to operate reliably and correctly. The Company's products are designed to address a wide range of applications across a broad array of end markets. The Company operates a fabless business model and leverages its international network of distributors to address the end markets it serves. The Company operates in one reportable segment related to the design, development, and sale of silicon timing systems solutions. It operates in Hong Kong, Taiwan, the United States, Singapore, and other regions, with the majority of revenue coming from Hong Kong.